Another study showed that brain metastatic cells from lung cancer could express high levels of anti‐plasminogen activator serpins, including neuroserpin and serpin B2, to prevent plasmin generation and its metastasis‐suppressive effects, which may become promising targets for NSCLC patients with BM 51. The gene discussed is PLG; the disease is non-small cell lung carcinoma.